Opinion: The Impact Factor, Re-envisioned

A combination of the traditional metric and the newer h5 index potentiates the scientific community toward more-balanced evaluation.

Written byShibo Jiang, Haoyang Li, and Yan Wang
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

© ISTOCKPHOTO.COM/ELLICA_S Even as Eugene Garfield proposed the impact factor more than half a century ago, he had reservations. “I expected it to be used constructively while recognizing that in the wrong hands it might be abused,” he said in a presentation he gave at the International Congress on Peer Review and Biomedical Publication in September 2005.

Indeed, while Garfield had intended the measure to help scientists search for bibliographic references, impact factor (IF) was quickly adopted to assess the influence of particular journals and, not long after, of individual scientists. It has since become a divisive term in the scientific community, with young researchers still striving to demonstrate their worthy within the confines of an antiquated publishing system. In the meantime, waves of criticisms against impact factor have arisen, including the difficulty in consistent reproduction and the easy manipulation of its value (e.g., by encouraging self-citations). “In 1955, it did not occur to me that ‘impact’ would one day become so controversial,” Garfield, founding editor of The Scientist, said in his 2005 presentation. “Like nuclear energy, the impact factor is a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies